Tianyin Pharmaceutical (TPI)
Add to Watchlists Create an Alert
0.62
+0.02 +3.33%
AMEX
May 24, 8:00PM
BATS Real time
Currency in USD
Tianyin Pharmaceutical Revenue Quarterly YoY Growth:
-3.47% for Dec. 31, 2012Tianyin Pharmaceutical Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -3.47% |
| Sept. 30, 2012 | -8.88% |
| June 30, 2012 | -15.43% |
| March 31, 2012 | -42.29% |
| Dec. 31, 2011 | -28.01% |
| Sept. 30, 2011 | -20.15% |
| June 30, 2011 | 17.05% |
| March 31, 2011 | 56.31% |
| Dec. 31, 2010 | 69.61% |
| Sept. 30, 2010 | 63.75% |
| June 30, 2010 | 47.96% |
| March 31, 2010 | 60.31% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
TPI Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Acura Pharmaceuticals | |
| Horizon Pharma | 91.35% |
| Sagent Pharmaceuticals | 57.29% |
TPI Revenue Quarterly YoY Growth Rankings
| Overall |
53rd percentile 3518 of 7600 |
| Sector |
45th percentile 359 of 653 in Healthcare |
| Industry |
46th percentile 35 of 66 in Drug Manufacturers - Specialty & Generic |
TPI Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -42.29% | Mar 2012 |
| Maximum | 58523% | Jun 2008 |
| Average | 3272% |
